Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05686928 · ClinicalTrials.gov registry record · Phase 4
Healing Ointment Usage Post-surgical Procedure
A Phase 4 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT05686928: Completed Phase 4 study, sponsored by Galderma R&D.
NCT05686928 is a Phase 4 study that has completed, run by Galderma R&D. The registered enrollment target is 15 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05686928, a Phase 4 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
To evaluate benefits of a Healing Ointment in skin improvement after dermatologic procedures
Primary Outcome
Summary of change in tolerability from baseline to day 28, at the surgical area after using the Healing Ointment daily. Lower scores reflect a better outcome. Erythema assessment was graded clinically based on a scale from 0 to 3 (0 = none, 1 = mild, 2 = moderate, 3 = severe).
Interventions
- DRUG Cetaphil Healing Ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-08-17 |
| Est. Completion | 2022-11-30 |
| Phase | Phase 4 |
What the finished NCT05686928 record still lists
NCT05686928 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Cetaphil Healing Ointment is the first listed.
NCT05686928 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05686928 about?
NCT05686928 is a clinical study titled "Healing Ointment Usage Post-surgical Procedure". To evaluate benefits of a Healing Ointment in skin improvement after dermatologic procedures
What is the current status of trial NCT05686928?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2022-08-17. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT05686928?
The interventions under investigation include: Cetaphil Healing Ointment (DRUG).
Who is sponsoring clinical trial NCT05686928?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05686928's enrollment target sits among peer trials
15 1880th of 2000 higher than 100 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI